KIAA0040 enhances glioma growth by controlling the JAK2 / STAT3 signalling pathway
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Jie He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Cell Movement, Cell Proliferation, Gene Expression Regulation, Neoplastic, Glioma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The role of KIAA0040 role in glioma development is not yet understood despite its connection to nervous system diseases. In this study, KIAA0040 expression levels were evaluated using qRT‐PCR, WB and IHC, and functional assays were conducted to assess its impact on glioma progression, along with animal experiments. Moreover, WB was used to examine the impact of KIAA0040 on the JAK2/STAT3 signalling pathway. Our study found that KIAA0040 was increased in glioma and linked to tumour grade and poor clinical outcomes, serving as an independent prognostic factor. Functional assays showed that KIAA0040 enhances glioma growth, migration and invasion by activating the JAK2/STAT3 pathway. Of course, KIAA0040 enhances glioma growth by preventing tumour cell death and promoting cell cycle advancement. Our findings suggest that targeting KIAA0040 could be an effective treatment for glioma due to its role in promoting aggressive tumour behaviour and poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Information and Data Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Chuansheng Nie
Zitieren
APA
He, J., Xue, K., Fan, F., Li, L., Rao, X., Liu, W., & Nie, C. (2024). KIAA0040 enhances glioma growth by controlling the JAK2 / STAT3 signalling pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18332
Vancouver
He J, Xue K, Fan F, Li L, Rao X, Liu W, et al. KIAA0040 enhances glioma growth by controlling the JAK2 / STAT3 signalling pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18332
BibTeX
@article{He2024,
author = {He, Jie and Xue, Kaming and Fan, Fei and Li, Lin and Rao, Xinyu and Liu, Wei and Nie, Chuansheng},
title = {KIAA0040 enhances glioma growth by controlling the JAK2 / STAT3 signalling pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18332}
}
EUVIMED